143 related articles for article (PubMed ID: 3135423)
1. [Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
Hattori H; Mikuriya S; Mamiya T; Hatano K; Shiina T; Yamada T
Gan No Rinsho; 1988 Jun; 34(7):851-6. PubMed ID: 3135423
[TBL] [Abstract][Full Text] [Related]
2. [A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer].
Yamamura Y; Nishimura M; Sakamoto J; Yasui K; Morimoto T; Kato T; Yasue M; Kito T; Miyaishi S; Nakazato H
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2134-40. PubMed ID: 3087293
[TBL] [Abstract][Full Text] [Related]
3. [Chemoembolization therapy of liver cancer combined with lipiodol and OK-432 intra-arterial administration].
Inoue H; Kobayashi H; Kajiya Y; Hidaka H; Ikeda K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):620-2. PubMed ID: 3006597
[No Abstract] [Full Text] [Related]
4. [Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
Yamamura Y; Yasue M; Kito T; Nakazato H; Yamada E
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1603-9. PubMed ID: 6409009
[TBL] [Abstract][Full Text] [Related]
5. [Intraoperative intraperitoneal administration of mitomycin C and OK-432 for peritoneal dissemination of gastric cancer].
Sugiyama Y; Yoshida A; Takao H; Kunieda K; Miya K; Azuma S; Tanemura H; Furuta T; Saji S
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1592-5. PubMed ID: 2117890
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
Andersson M; Daugaard S; von der Maase H; Mouridsen HT
Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
[TBL] [Abstract][Full Text] [Related]
7. [Case of malignant melanoma of the external genitalia responding satisfactorily to a combination of local injection of OK-432 and chemotherapy].
Satoh S; Suzuki A; Okamura H; Nishimura T
Gan To Kagaku Ryoho; 1982 Jan; 9(1):140-5. PubMed ID: 6820877
[TBL] [Abstract][Full Text] [Related]
8. [Randomized controlled study of OK-432 in the treatment of cancerous pleurisy].
Urata A; Nishimura M; Ota K
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1497-503. PubMed ID: 6409006
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative combination therapy involving local administration of a non-specific immunoactivated preparation (OK-432) and chemotherapeutic preparations for patients with stomach cancer].
Mukai M; Ryu S; Kikuchi T; Ariga T; Nagashima T; Koh Z; Yamazaki Y; Odaka M; Satoh H; Nagao K
Gan To Kagaku Ryoho; 1985 Apr; 12(4):880-6. PubMed ID: 3920972
[TBL] [Abstract][Full Text] [Related]
10. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Mukai M; Den N; Yamazaki Y; Namiki S; Oda S; Nagao K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880
[TBL] [Abstract][Full Text] [Related]
11. [Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa].
Shimizu E; Saijo N; Shinkai T; Eguchi K; Tominaga K; Nomori H; Sasaki Y; Garcia-Herreros P; Hoshi A
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1290-5. PubMed ID: 6732255
[TBL] [Abstract][Full Text] [Related]
12. [Study on adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer].
Kikkawa N; Kawahara T
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1881-5. PubMed ID: 3382240
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative immunochemotherapy for gastric cancer combined with perifocal administration of OK-432].
Mukai M; Yamazaki Y; Amano H; Hiura T; Oda S; Namiki S; Nakajima K; Nagao K
Gan To Kagaku Ryoho; 1984 May; 11(5):1071-7. PubMed ID: 6426402
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic arterial infusion of degradable starch microspheres (DSM) with adriamycin or mitomycin C in liver cancer].
Ota J; Fujita M; Nakamura H; Taguchi T
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2640-5. PubMed ID: 3137887
[TBL] [Abstract][Full Text] [Related]
15. [Intra-arterial infusion chemotherapy with anticancer agents for advanced breast cancer--effect and toxicity of mitomycin C and adriamycin].
Toda K; Asaishi K; Okazaki A; Okazaki Y; Okazaki M; Ebata T; Totsuka M; Hayasaka H; Sato N; Narimatsu E
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2298-304. PubMed ID: 2934023
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of a combination of UFT, MMC, and OK-432 for advanced gastro-intestinal cancer].
Misawa S; Yashige H; Nishigaki H; Horiike S; Tsuda S; Abe T; Takino T; Taniwaki M; Takeda S; Tsuji T
Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2427-35. PubMed ID: 3130449
[No Abstract] [Full Text] [Related]
17. [Intraarterial combination immunotherapy in hepatocellular carcinoma].
Hazama S; Oka M; Shimizu R; Yano K; Yoshino S; Iizuka N; Murakami T; Suzuki T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1638-42. PubMed ID: 2167639
[TBL] [Abstract][Full Text] [Related]
18. [MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
Sakata Y; Yoshida Y; Komatsu Y; Sugawara K; Nishimura S; Kikuchi K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):109-15. PubMed ID: 6820875
[TBL] [Abstract][Full Text] [Related]
19. [A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer].
Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Abe O; Kikuchi K; Tanabe T; Ogawa N
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1850-63. PubMed ID: 3929694
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of urothelial cancer with vincristine, mitomycin C, bleomycin, tegafur and OK-432].
Fujihiro S; Takeuchi T; Fujimoto Y; Okano M; Horie M; Kanematsu M; Kuriyama M; Ban Y; Nishiura T
Gan To Kagaku Ryoho; 1984 Mar; 11(3):427-32. PubMed ID: 6200077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
